Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Use of metrics to quantify IMRT and VMAT treatment plan complexity: A systematic review and perspectives.

Antoine M, Ralite F, Soustiel C, Marsac T, Sargos P, Cugny A, Caron J.

Phys Med. 2019 Aug;64:98-108. doi: 10.1016/j.ejmp.2019.05.024. Epub 2019 Jul 9.

PMID:
31515041
2.

[Prophylactic nodal radiotherapy in prostate cancer].

Bourdais R, Achkar S, Chauffert-Yvart L, Pasquier D, Sargos P, Blanchard P, Latorzeff I.

Cancer Radiother. 2019 Oct;23(6-7):688-695. doi: 10.1016/j.canrad.2019.07.149. Epub 2019 Aug 23. Review. French.

PMID:
31451356
3.

[Stereotactic ablative body radiotherapy: Which machine for which therapeutic indication? A focus on prostate cancer].

Lapierre A, Horn S, Créhange G, Enachescu C, Latorzeff I, Supiot S, Sargos P, Hennequin C, Chapet O.

Cancer Radiother. 2019 Oct;23(6-7):651-657. doi: 10.1016/j.canrad.2019.06.009. Epub 2019 Aug 22. Review. French.

PMID:
31447340
4.

Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.

Amestoy F, Roubaud G, Antoine M, Fonteyne V, Baumann BC, Christodouleas J, Roupret M, Azria D, Zilli T, Hennequin C, Xylinas E, Sargos P; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology.

Crit Rev Oncol Hematol. 2019 Oct;142:76-85. doi: 10.1016/j.critrevonc.2019.06.010. Epub 2019 Jul 16. Review.

PMID:
31377435
5.

Long-term androgen deprivation, with or without radiotherapy, in locally-advanced prostate cancer: updated results from a phase III randomized trial.

Sargos P, Mottet N, Bellera C, Richaud P.

BJU Int. 2019 Apr 4. doi: 10.1111/bju.14768. [Epub ahead of print]

PMID:
30946523
6.

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

Mirjolet C, Merlin JL, Truc G, Noël G, Thariat J, Domont J, Sargos P, Renard-Oldrini S, Ray-Coquard I, Liem X, Chevreau C, Lagrange JL, Mahé MA, Collin F, Bonnetain F, Bertaut A, Maingon P.

EBioMedicine. 2019 Mar;41:420-426. doi: 10.1016/j.ebiom.2019.02.031. Epub 2019 Mar 1.

7.

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.

Fischer-Valuck BW, Michalski JM, Contreras JA, Brenneman R, Christodouleas JP, Abraham CD, Kim EH, Arora VK, Bullock AD, Carmona R, Figenshau RS, Grubb R 3rd, Knoche EM, Pachynski RK, Picus J, Roth BJ, Sargos P, Andriole GL, Gay HA, Baumann BC.

Clin Transl Radiat Oncol. 2018 Dec 12;15:38-41. doi: 10.1016/j.ctro.2018.12.001. eCollection 2019 Feb.

8.

[Chemoradiation for oesophageal cancer: A critical review of the literature].

Blais E, Vendrely V, Sargos P, Créhange G, Huguet F, Maingon P, Simon JM, Bourdais R, Ozsahin M, Bourhis J, Clément-Colmou K, Belghith B, Proudhom Briois MA, Gilliot O, Dujols JP, Peyras A, Dupin C, Riet FG, Canova CH, Huertas A, Troussier I.

Cancer Radiother. 2019 Feb;23(1):62-72. doi: 10.1016/j.canrad.2018.05.003. Epub 2019 Jan 11. Review. French.

PMID:
30639379
9.

Radiation Therapy in Resectable Intrathoracic Sarcomas. A Rare Cancer Network Study.

Larsen F, Terlizzi M, Linacre V, Sargos P, Suarez F, Kirova Y, Van Houtte P, Lerouge D, Zilli T, Sole CV.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1175-1181. doi: 10.1016/j.ijrobp.2018.12.022. Epub 2018 Dec 20.

PMID:
30578911
10.

Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).

Vaugier L, Palpacuer C, Rio E, Goineau A, Pasquier D, Buthaud X, De Laroche G, Beckendorf V, Sargos P, Créhange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Campion L, Supiot S.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1061-1067. doi: 10.1016/j.ijrobp.2018.12.020. Epub 2018 Dec 14.

11.

Management of non-metastatic castrate-resistant prostate cancer: A systematic review.

Loriot Y, Supiot S, Beauval JB, Schlürmann F, Pasticier G, Sargos P, Barthélémy P, Pignot G, Maillet D, Vincendeau S, Gross E, Ploussard G, Timsit MO, Borchiellini D.

Cancer Treat Rev. 2018 Nov;70:223-231. doi: 10.1016/j.ctrv.2018.09.006. Epub 2018 Sep 21. Review.

PMID:
30300771
12.

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy.

Boughzala-Bennadji R, Stoeckle E, Le Péchoux C, Méeus P, Honoré C, Attal J, Duffaud F, De Pinieux G, Bompas E, Thariat J, Leroux A, Bertucci F, Isambert N, Delcambre C, Blay JY, Sunyach MP, Coindre JM, Sargos P, Penel N, Bonvalot S.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):399-406. doi: 10.1016/j.ijrobp.2018.05.055. Epub 2018 Jun 2.

PMID:
30191871
13.

[Hypofractionnated radiotherapy for elderly patients with prostate cancer].

Sargos P, Créhange G, Hennequin C, Latorzeff I, de Crevoisier R, Roubaud G, Supiot S.

Cancer Radiother. 2018 Oct;22(6-7):631-634. doi: 10.1016/j.canrad.2018.07.124. Epub 2018 Aug 23. Review. French.

PMID:
30145092
14.

Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy.

Sargos P, Baumann BC, Eapen L, Christodouleas J, Bahl A, Murthy V, Efstathiou J, Fonteyne V, Ballas L, Zaghloul M, Roubaud G, Orré M, Larré S.

Cancer Treat Rev. 2018 Nov;70:88-97. doi: 10.1016/j.ctrv.2018.07.011. Epub 2018 Jul 21. Review.

PMID:
30125800
15.

Systemic treatments for high-risk localized prostate cancer.

Pignot G, Maillet D, Gross E, Barthelemy P, Beauval JB, Constans-Schlurmann F, Loriot Y, Ploussard G, Sargos P, Timsit MO, Vincendeau S, Pasticier G, Borchiellini D.

Nat Rev Urol. 2018 Aug;15(8):498-510. doi: 10.1038/s41585-018-0017-x. Review.

PMID:
29765147
16.

Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial.

Maillot O, Leduc N, Atallah V, Escarmant P, Petit A, Belhomme S, Sargos P, Vinh-Hung V.

Cancer Radiother. 2018 May;22(3):205-210. doi: 10.1016/j.canrad.2017.10.007. Epub 2018 Apr 17.

PMID:
29678596
17.

[Radiation therapy in patients with inflammatory bowel disease. A review].

Jmour O, Pellat A, Colson-Durand L, To NH, Latorzeff I, Sargos P, Sobhani I, Belkacemi Y.

Bull Cancer. 2018 May;105(5):517-522. doi: 10.1016/j.bulcan.2018.02.005. Epub 2018 Apr 10. Review. French.

PMID:
29653817
18.

Re: Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.

Moschini M, Sargos P; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology.

Eur Urol. 2018 Jul;74(1):119. doi: 10.1016/j.eururo.2018.03.022. Epub 2018 Apr 9. No abstract available.

PMID:
29650235
19.

Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations.

Langrand-Escure J, de Crevoisier R, Llagostera C, Créhange G, Delaroche G, Lafond C, Bonin C, Bideault F, Sargos P, Belhomme S, Pasquier D, Latorzeff I, Supiot S, Hennequin C.

Cancer Radiother. 2018 Apr;22(2):193-198. doi: 10.1016/j.canrad.2017.11.004. Epub 2018 Apr 5.

PMID:
29628205
20.

Pre- and postoperative radiotherapy for extremity soft tissue sarcoma: Evaluation of inter-observer target volume contouring variability among French sarcoma group radiation oncologists.

Sargos P, Charleux T, Haas RL, Michot A, Llacer C, Moureau-Zabotto L, Vogin G, Le Péchoux C, Verry C, Ducassou A, Delannes M, Mervoyer A, Wiazzane N, Thariat J, Sunyach MP, Benchalal M, Laredo JD, Kind M, Gillon P, Kantor G.

Cancer Radiother. 2018 Apr;22(2):131-139. doi: 10.1016/j.canrad.2017.09.004. Epub 2018 Mar 12.

PMID:
29545115
21.

Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG.

Beauval JB, Loriot Y, Hennequin C, Rozet F, Barthelemy P, Borchiellini D, Schlürmann Constans F, Gross E, Maillet D, Pasticier G, Pignot G, Timsit MO, Vincendeau S, Ploussard G, Sargos P.

Crit Rev Oncol Hematol. 2018 Feb;122:144-149. doi: 10.1016/j.critrevonc.2017.12.012. Epub 2017 Dec 30. Review.

PMID:
29458782
22.

Manual vs. automated implantation of seeds in prostate brachytherapy: Oncologic results from a single-center study.

Thomas L, Chemin A, Leduc N, Belhomme S, Rich E, Lasbareilles O, Giraud A, Descat E, Roubaud G, Sargos P.

Brachytherapy. 2018 Jan - Feb;17(1):214-220. doi: 10.1016/j.brachy.2017.09.013.

PMID:
29102738
23.

External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis.

Albertsmeier M, Rauch A, Roeder F, Hasenhütl S, Pratschke S, Kirschneck M, Gronchi A, Jebsen NL, Cassier PA, Sargos P, Belka C, Lindner LH, Werner J, Angele MK.

Ann Surg Oncol. 2018 Mar;25(3):754-767. doi: 10.1245/s10434-017-6081-2. Epub 2017 Sep 11.

PMID:
28895107
24.

Lung Adenocarcinoma Survival in EGFR-Mutated African-Caribbean Patients: A Multicenter Study in the French West Indies.

Leduc N, Atallah V, Agossou M, Vinh-Hung V, Orre M, Sargos P, Molinie V.

Target Oncol. 2017 Oct;12(5):689-693. doi: 10.1007/s11523-017-0512-7.

PMID:
28624921
25.

Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?

Latorzeff I, Sargos P, Loos G, Supiot S, Guerif S, Carrie C.

Front Oncol. 2017 May 31;7:108. doi: 10.3389/fonc.2017.00108. eCollection 2017.

26.

Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.

De Bari B, Stish B, Ball MW, Habboush Y, Sargos P, Krengli M, Bossi A, Stabile A, Sole Pesutic C, Lestrade L, Smeenk RJ, Jereczek-Fossa BA, Zilli T, Créhange G, Alongi F, Zaorsky N, Ozsahin M.

Prostate. 2017 Jul;77(10):1160-1166. doi: 10.1002/pros.23375. Epub 2017 Jun 8.

PMID:
28594087
27.

Tolerance of Orthotopic Ileal Neobladders to Radiotherapy: A Multi-institutional Retrospective Study.

Ballas L, Sargos P, Orré M, Bian SX, Daneshmand S, Eapen LJ.

Clin Genitourin Cancer. 2017 Dec;15(6):711-716. doi: 10.1016/j.clgc.2017.05.007. Epub 2017 May 10.

PMID:
28558986
28.

Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab.

Blaye C, Buy X, Gross-Goupil M, Vincent D, Jamet C, Sargos P, Culine S, Roubaud G.

Ther Adv Drug Saf. 2017 Apr;8(4):133-136. doi: 10.1177/2042098616682720. Epub 2017 Jan 16. No abstract available.

29.

Oncological and functional results of robotic salvage radical prostatectomy after permanent brachytherapy implants.

Orré M, Piéchaud T, Sargos P, Richaud P, Roubaud G, Thomas L.

Cancer Radiother. 2017 Apr;21(2):119-123. doi: 10.1016/j.canrad.2016.11.001. Epub 2017 Apr 7.

PMID:
28396223
30.

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study.

Savina M, Le Cesne A, Blay JY, Ray-Coquard I, Mir O, Toulmonde M, Cousin S, Terrier P, Ranchere-Vince D, Meeus P, Stoeckle E, Honoré C, Sargos P, Sunyach MP, Le Péchoux C, Giraud A, Bellera C, Le Loarer F, Italiano A.

BMC Med. 2017 Apr 10;15(1):78. doi: 10.1186/s12916-017-0831-7.

31.

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.

Orré M, Latorzeff I, Fléchon A, Roubaud G, Brouste V, Gaston R, Piéchaud T, Richaud P, Chapet O, Sargos P.

PLoS One. 2017 Apr 6;12(4):e0174978. doi: 10.1371/journal.pone.0174978. eCollection 2017.

32.

Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.

Vilotte F, Antoine M, Bobin M, Latorzeff I, Supiot S, Richaud P, Thomas L, Leduc N, Guérif S, Iriondo-Alberdi J, de Crevoisier R, Sargos P.

Front Oncol. 2017 Mar 9;7:34. doi: 10.3389/fonc.2017.00034. eCollection 2017. Review.

33.

Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?

Honoré C, Atallah V, Mir O, Orbach D, Ferron G, LePéchoux C, Delhorme JB, Philippe-Chomette P, Sarnacki S, Msika S, Terrier P, Glehen O, Martelli H, Minard-Colin V, Bertucci F, Blay JY, Bonvalot S, Elias D, LeCesne A, Sargos P; French Network for Rare Peritoneal Malignancies (RENAPE), French Pediatric Cancer Society (SFCE), French Reference Network in Sarcoma Pathology (RRePS) French Sarcoma Clinical Network (NETSARC).

PLoS One. 2017 Feb 24;12(2):e0171639. doi: 10.1371/journal.pone.0171639. eCollection 2017.

34.

The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series.

Stoeckle E, Michot A, Rigal L, Babre F, Sargos P, Henriques de Figueiredo B, Brouste V, Italiano A, Toulmonde M, Le Loarer F, Kind M.

Eur J Surg Oncol. 2017 Jun;43(6):1117-1125. doi: 10.1016/j.ejso.2017.01.018. Epub 2017 Feb 3.

PMID:
28202211
35.

[Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]

Sargos P, Larré S, Chapet O, Latorzeff I, Fléchon A, Roubaud G, Orré M, Belhomme S, Richaud P.

Cancer Radiother. 2017 Feb;21(1):67-72. doi: 10.1016/j.canrad.2016.08.131. Epub 2017 Feb 8. Review. French.

PMID:
28187997
36.

The Rationale for Post-Operative Radiation in Localized Bladder Cancer.

Baumann BC, Sargos P, Eapen LJ, Efstathiou JA, Choudhury A, Bahl A, Murthy V, Ballas LK, Fonteyne V, Richaud PM, Zaghloul MS, Christodouleas JP.

Bladder Cancer. 2017 Jan 27;3(1):19-30. doi: 10.3233/BLC-160081. Review.

37.

Helical tomotherapy of spinal chordomas: French Multicentric, retrospective study of a cohort of 30 cases.

Bobin M, Zacharatou C, Sargos P, Brouste V, Lisbona A, Mahé MA, Noël G, Halley A, Feuvret L, Gras L, Hoppe S, de Figueiredo BH, Kantor G.

Radiat Oncol. 2017 Jan 31;12(1):32. doi: 10.1186/s13014-017-0768-1.

38.

Curative brachytherapy for prostate cancer in African-Caribbean patients: A retrospective analysis of 370 consecutive cases.

Atallah V, Leduc N, Creoff M, Sargos P, Taouil T, Escarmant P, Vinh-Hung V.

Brachytherapy. 2017 Mar - Apr;16(2):342-347. doi: 10.1016/j.brachy.2016.11.006. Epub 2016 Dec 23.

PMID:
28024937
39.

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.

Bonvalot S, Le Pechoux C, De Baere T, Kantor G, Buy X, Stoeckle E, Terrier P, Sargos P, Coindre JM, Lassau N, Ait Sarkouh R, Dimitriu M, Borghi E, Levy L, Deutsch E, Soria JC.

Clin Cancer Res. 2017 Feb 15;23(4):908-917. doi: 10.1158/1078-0432.CCR-16-1297. Epub 2016 Oct 6.

40.

Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?

Sargos P, Baumann BC, Eapen LJ, Bahl A, Murthy V, Roubaud G, Orré M, Efstathiou JA, Shariat S, Larré S, Richaud P, Christodouleas JP.

Transl Androl Urol. 2016 Oct;5(5):702-710. Review.

41.

[Surgery for soft-tissue sarcomas of the limbs and trunk wall].

Stoeckle E, Michot A, Henriques B, Sargos P, Honoré C, Ferron G, Meeus P, Babre F, Bonvalot S.

Cancer Radiother. 2016 Oct;20(6-7):657-65. doi: 10.1016/j.canrad.2016.07.068. Epub 2016 Sep 3. French.

PMID:
27599681
42.

[Radiotherapy for retroperitoneal sarcomas].

Sargos P, Stoeckle E, Henriques de Figueiredo B, Antoine M, Delannes M, Mervoyer A, Kantor G.

Cancer Radiother. 2016 Oct;20(6-7):677-84. doi: 10.1016/j.canrad.2016.07.040. Epub 2016 Aug 24. Review. French.

PMID:
27568294
43.

[Radiotherapy of adult soft tissue sarcoma].

Le Péchoux C, Moureau-Zabotto L, Llacer C, Ducassou A, Sargos P, Sunyach MP, Thariat J.

Cancer Radiother. 2016 Sep;20 Suppl:S235-43. doi: 10.1016/j.canrad.2016.07.028. Epub 2016 Aug 11. French.

PMID:
27523415
44.

Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy.

Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani A, Malkowicz SB, Mantz CA, Master V, Mitra AV, Murthy V, Porten SP, Richaud PM, Sargos P, Efstathiou JA, Eapen LJ, Christodouleas JP.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):78-86. doi: 10.1016/j.ijrobp.2016.04.032. Epub 2016 May 7. Erratum in: Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1129.

45.

Role of Adjuvant Radiation Therapy After Surgery for Abdominal Desmoplastic Small Round Cell Tumors.

Atallah V, Honore C, Orbach D, Helfre S, Ducassou A, Thomas L, Levitchi MB, Mervoyer A, Naji S, Dupin C, Bosco-Levy PJ, Philippe-Chomette P, Kantor G, Henriques de Figueiredo B, Sunyach MP, Sargos P.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1244-53. doi: 10.1016/j.ijrobp.2016.02.046. Epub 2016 Feb 19.

PMID:
27354131
46.

Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group.

Fourquet J, Sunyach MP, Vilotte F, Le Péchoux C, Ranchère-Vince D, Bonvalot S, Coindre JM, Terrier P, Meeus P, Helfre S, Martin E, Vogin G, Biau J, Kao W, Noel G, Ducassou A, Llacer-Moscardo C, Stoeckle E, Penel N, Sargos P.

Radiother Oncol. 2016 Jul;120(1):156-62. doi: 10.1016/j.radonc.2016.04.037. Epub 2016 May 17.

PMID:
27207359
47.

[Management of soft tissues sarcoma of the limbs by external beam radiation therapy].

Moureau-Zabotto L, Delannes M, Le Péchoux C, Sunyach MP, Kantor G, Sargos P, Thariat J, Llacer-Moscardo C.

Cancer Radiother. 2016 Apr;20(2):133-40. doi: 10.1016/j.canrad.2015.10.002. Epub 2016 Mar 16. Review. French.

PMID:
26995071
48.

Prise en charge des tumeurs germinales du testicule en Aquitaine : état des lieux des pratiques en 2012.

Ferretti L, Gross-Goupil M, Sargos P, Cirilo Cassaigne I, Gaucher B, Demeaux H, Bousser V, Lebras Y, Pasticier G, Richaud P, Yacoub M, Roubaud G, Digue L.

Prog Urol. 2015 Nov;25(13):855. doi: 10.1016/j.purol.2015.08.280. French. No abstract available.

PMID:
26544475
49.

Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).

Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Créhange G, Chapet O, de Crevoisier R, Azria D, Supiot S, Habibian M, Soulié M, Richaud P.

Cancer Treat Rev. 2015 Dec;41(10):814-20. doi: 10.1016/j.ctrv.2015.10.005. Epub 2015 Oct 23. Review.

PMID:
26508669
50.

Enzalutamide and sleep apnea: an emerging central nervous system side-effect?

Labrize F, Cany L, Massard C, Loriot Y, Sargos P, Gross-Goupil M, Roubaud G.

Ann Oncol. 2016 Jan;27(1):206. doi: 10.1093/annonc/mdv481. Epub 2015 Oct 7. No abstract available.

PMID:
26445811

Supplemental Content

Loading ...
Support Center